α-MSH also induces melanogenesis in melanocytes and melanoma cells but this process is slow54: melanins do not appear before 1–3 days after initial treatment with MSH peptides, i.e. at an interval when therapy sessions have long been terminated. The gene discussed is STAMBP; the disease is melanoma.